The S&P/ASX 200 Index (ASX: XJO) is on form on Wednesday and charging higher. At the time of writing, the benchmark index is up 0.7% to 8,598.3 points.

Four ASX shares that are rising more than most today are listed below. Here’s why they are climbing:

DroneShield Ltd (ASX: DRO)

The DroneShield share price is up 8.5% to $2.17. This is despite there being no news out of the counter drone technology company. However, with its shares down heavily in recent weeks, it seems that some investors believe they are now a bargain buy. Bell Potter appears to agree. It recently put a buy rating and $5.30 price target on its shares.

Electro Optic Systems Holdings Ltd (ASX: EOS)

The EOS share price is up over 7% to $4.78. This follows news that the defence company has completed a key acquisition and settled ASIC’s investigation in relation to certain disclosure matters in 2022. The settlement includes an agreed proposed penalty of $4 million. As for the acquisition, EOS has completed the deal to acquire the UK-based Interceptor business from MARSS Group for $10 million.

Gentrack Group Ltd (ASX: GTK)

The Gentrack share price is up a further 5% to $8.93. This airport and utilities software provider’s shares have been rocketing this week thanks to the release of its FY 2025 results. Gentrack posted an 8% increase in revenue to NZ$230.2 million and an 18% jump in EBITDA to NZ$27.8 million. Management also reiterated its mid-term target of more than 15% compound annual revenue growth and an EBITDA margin of 15%–20%. Bell Potter was pleased and retained its buy rating on its shares with an improved price target of $11.00. Gentrack’s shares are now up 33% this week.

Web Travel Group Ltd (ASX: WEB)

The Web Travel share price is up a further 6% to $4.63. This travel technology company’s shares have been flying this week following the release of its half year results on Tuesday. Web Travel posted a 22% lift in total transaction value (TTV) to a record of $3.17 billion and a 17% jump in underlying EBITDA to a record of $81.7 million. Commenting on its performance, Web Travel’s managing director, John Guscic, said: “WebBeds continues to deliver world class TTV growth. We reported $3.2 billion TTV for the first 6 months of the financial year, 22% more than the same period last year, driven by the significant above-market growth coming through in our top 3 regions, particularly the Americas.” This morning, Macquarie put an outperform rating and $6.85 price target on its shares.

The post Why DroneShield, EOS, Gentrack, and Web Travel shares are surging today appeared first on The Motley Fool Australia.

More reading

• Why is this ASX defence stock rocketing 10% today?
• Buy this ASX tech stock before it’s too late: Bell Potter
• Leading analysts name 3 ASX 200 titans to buy today
• Why are DroneShield shares flying 16% higher on Tuesday?
• Why Gentrack, IPD, SRG, and Web Travel shares are racing higher today

Motley Fool contributor James Mickleboro has positions in Web Travel Group Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield, Electro Optic Systems, Gentrack Group, and Macquarie Group. The Motley Fool Australia has positions in and has recommended Gentrack Group and Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The recent sell off across the S&P/ASX 200 Index (ASX: XJO) has hit tech stocks disproportionately, Wilsons Advisory says, creating two buying opportunities in particular.

In a research note to clients, Wilsons says the circa-6% fall in the ASX 200 has been accompanied by a far sharper sell off across Australian-listed technology stocks of about 25%.

As the Wilsons team says:

This is the largest drawdown in local tech stocks since the April ‘Liberation Day’ correction and stands in stark contrast to offshore markets, with the Nasdaq Composite for instance only about 7% below its recent highs and the S&P 500 IT sector down about 10% – highlighting the disproportionate pressure on Australian tech names.

Reasons for the large sell off include “demanding” valuations for many companies, meaning that, “even modestly underwhelming updates from WiseTech, TechnologyOne and Xero have been enough to trigger a sharp rotation out of the sector”.

Xero Ltd (ASX: XRO) and Wisetech Ltd (ASX: WTC) have also been dealing with the integration of major acquisitions, with the US$2.5 billion purchase of Melio by Xero and Wisetech’s US$2.1 billion buyout of e2open.

Wilsons said:

Both deals have clear strategic merit, but carry integration risks, while they also face an ASX investor base that is generally sceptical of large offshore M&A. In Xero’s case, the sizable capital raise appears to have contributed to material stock indigestion, with seemingly few incremental buyers for the stock post the raise.

Uncertainty creating opportunity

So who does Wilson like in the sector? The Wilsons team said the recent pullback in technology stock prices “appears to have created attractive buying opportunities”.

While past performance is not a reliable predictor of future returns, drawdowns of more than 10% have historically presented attractive buying opportunities in the tech sector for patient capital willing to look through near-term volatility. With the current drawdown, at about 25%, marking only the fifth drawdown of 20% or more in the past decade – and the largest since the ‘Liberation Day’ tariffs in April – this pullback appears to offer a relatively rare opportunity to accumulate high-quality tech names at discounted entry prices.

The first stock Wilsons has named as a key pick is TechnologyOne Ltd (ASX: TNE), which has fallen about 15% since reporting its full-year results recently.

Wilsons said the result was broadly positive despite some numbers coming in slightly below consensus, with pre-tax profit up 19%, well ahead of guidance of 13%-17%.

As the Wilsons team said:

Despite small misses on select line items, TechnologyOne’s fundamental outlook remains intact. The decline in (the) share price following its result largely reflects the correction of its supernormal valuation – with forward P/E having recently peaked at about 90x – leaving effectively no margin for even a very modest miss at reporting. Most importantly, TechnologyOne continues to execute exceptionally well, and our conviction in the outlook remains as positive as ever.

With the company’s valuation on a price-to-earnings (P/E) ratio basis now back within its “normal” historical range, “this presents a rare opportunity to invest into one of the ASX’s highest-quality earnings compounders at a relatively attractive valuation”, Wilsons says.

They also note that “Canaccord Genuity Research has a 12-month price target of $42.15, representing 40% upside to the last close”.

Plenty of runway for growth

Wilsons’ other key pick is accounting software firm Xero, which they said delivered a slightly softer than expected first-half result recently.

However, we remain constructive on the medium-term growth outlook and view the 14% share-price decline as overdone. With the stock already under pressure heading into the print, the pullback creates a particularly attractive entry point for investors with the medium-term growth story remaining intact.

Wilsons said they remain confident that earnings will continue to grow, underpinned by healthy subscriber growth and average revenue per user expansion, plus the monetisation of artificial intelligence tools.

Overall, with the growth story remaining firmly intact, Xero offers attractive value at current levels.

The post Two ASX tech stocks Wilsons Advisory says are a buy after the recent tech sell-off appeared first on The Motley Fool Australia.

More reading

• This ASX tech share could quietly become a global leader
• 2 top ASX shares I’d buy with $2,000 right now
• Bear market alert: ASX 200 tech shares down 24% since September peak
• These ASX 200 shares could rise 40% to 90%
• No savings at 55? Here’s how to still retire with passive income

Motley Fool contributor Cameron England has positions in WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 0.6% to 8,590.6 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are falling:

Meteoric Resources NL (ASX: MEI)

The Meteoric Resources share price was down 4.5% to 57.5 cents before being placed into a trading halt. Its trading halt request states: “Meteoric is seeking the trading halt pending release of an announcement in response to media speculation in relation to the Preliminary License (LP) approval process.” There is speculation that authorities in Brazil have recommended that the preliminary license for its rare earth mining project be suspended urgently. This would be a big blow to the rare earths developer.

Race Oncology Ltd (ASX: RAC)

The Race Oncology share price is down 9% to $2.64. This is despite the announcement of a positive development from the oncology company this morning, Race revealed that it has received human ethics approval from the St Vincents Hospital Melbourne Human Research Ethics Committee (HREC) to initiate a Phase 1a/b clinical trial. It will assess the safety, tolerability, and pharmacokinetics (PK) of RC220 with Osimertinib. This will be in patients with non-small cell lung cancer that have activating epidermal growth factor receptor mutations. Patient enrolment is subject to final institutional approval and site activation by Monash Health, which is expected in late Q4 2025 to early Q1 2026.

Temple & Webster Group Ltd (ASX: TPW)

The Temple & Webster share price is down 33% to $13.67. This morning, this online homewares retailer reported an 18% increase in sales for July to 20 November. While this is sales growth that most companies would be envious of, the market was expecting an even stronger growth rate for the first half of FY 2026. They don’t appear to believe that Temple & Webster will be able to make up the ground over the final weeks of the half.

West African Resources Ltd (ASX: WAF)

The West African Resources share price is down over 13% to $2.63. This gold miner’s shares have crashed down to earth after returning from a three-month suspension. The gold miner has been busy negotiating with the Burkina Faso government after it requested a larger equity interest in its Kiaka operation. West African Resources’ chair and CEO, Richard Hyde ,said: “Our discussions regarding the ownership structure of our recently constructed Kiaka Project have reflected a shared vision to develop a strong and sustainable mining industry that benefits the Burkinabe people and delivers long-term value for all stakeholders. Sanbrado and Toega have not been part of these discussions.”

The post Why Meteoric Resources, Race, Temple & Webster, and West African shares are falling today appeared first on The Motley Fool Australia.

More reading

• This furniture outfit has delivered a big miss on sales expectations, with its shares smashed as a result
• Why is this top ASX 200 gold stock crashing 15% on Wednesday?
• 3 amazing ASX growth shares to buy and hold forever
• 3 outstanding ASX growth shares analysts are backing right now
• Why James Hardie, Meteoric Resources, Pilbara Minerals, and SKS shares are rising today

Motley Fool contributor James Mickleboro has positions in Temple & Webster Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia has recommended Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Qube Holdings Limited (ASX: QUB) share price has climbed 0.52% higher again on Wednesday morning. At the time of writing the shares are trading at $4.86 a piece. For the year, the shares are 21.5% higher.

Much of that growth happened when Qube shares surged 19.4% to a record high of $4.86 on Monday this week. 

What happened?

Qube is Australia’s leading provider of logistics solutions, with a primary focus on import and export supply chains. The company comprises two core units: its logistics operating division and the company’s 50% interest in Patrick Terminals, Australia’s leading container terminal operator.

Its operations business unit covers road and rail transport, warehousing and distribution, container parks, automotive terminals, and grain storage and handling. It also provides comprehensive logistics services and solutions at more than 40 ports in Australia, New Zealand, and Southeast Asia. 

Its Patrick Terminals business is a leading terminal operator providing container stevedoring services in the Australian market. 

Investor interest in Qube rocketed this week after the company announced that Macquarie Assessment Management has launched a $11.6 billion takeover bid for the company. Investors were falling over themselves to snap up the stock, which sent the company’s share price soaring. 

Macquarie is offering $5.20 per share for the logistics provider, well above its current record-breaking trading price. It means that shares purchased today could be worth 7% more following a successful takeover. 

The takeover bid is conditional on several factors, including completion of due diligence and a unanimous recommendation from the Qube board.

The board stated on Monday that it had granted Macquarie a period of exclusive due diligence until 1 February. It also indicated that, at this stage, the directors intend to support the proposal unanimously, provided that the deal is in the best interest of the shareholders.

If the acquisition is successful, it would be Macquarie’s largest ever completed transaction in Australia.

Qube is well-positioned to continue record growth

Macquarie’s takeover bid for Qube shares is timely, given that the company held its annual general meeting (AGM) last Thursday. The company announced that in FY25, it achieved a record underlying revenue of $4.46 billion, representing a 27.3% year-over-year increase. Qube also lifted its fully franked full-year dividend by 7.1% to 9.8 cents per share.

Qube anticipates that it can maintain this growth momentum in FY26. And management has already confirmed that the company’s financial performance in Q1 FY26 is in line with expectations. 

So, are Qube shares a buy?

Macquarie’s takeover bid presents a clear upside for Qube shares, and it appears likely that the board will support the deal. Qube’s board has already agreed to grant Macquarie exclusive due diligence and stated that it will support the deal in the absence of a better offer.

But it’s important to note that the deal is not final yet. It is still non-binding, which means it is subject to due diligence and other approvals.

There is also a risk that if the deal is delayed or falls through for any reason, the current share price could be at risk. 

The post Why is everyone talking about Qube shares? appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Why Gentrack, Monash IVF, Pro Medicus, and Qube shares are racing higher today
• Qube shareholders sitting pretty after Macquarie takeover bid launched
• Qube Holdings holds AGM after hitting record earnings in FY25

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Shares in Abacus Storage King (ASX: ASK) have charged more than 10% higher in early trade on Wednesday, and I’ve got a pretty good idea why.

Abacus is a player in the booming self-storage industry in Australia and has grown to be worth $1.83 billion after listing on the ASX in August 2023.

Takeover in the wings

One of the company’s key competitors, and a shareholder in Abacus itself, is National Storage REIT (ASX: NSR), which on Wednesday asked that its shares be placed in a trading halt.

NSR, as reported by The Australian, is currently fielding a potential takeover offer purportedly from Brookfield and GIC, and has asked that its shares be suspended while negotiations continue.

It’s my bet that traders are looking at the potential NSR deal and wondering whether Abacus might be wrapped into a larger play either now or down the track.

Abacus in predators’ rights

Abacus has this year been itself the target of a protracted takeover attempt by Ki Corporation and US-listed firm Public Storage (NYSE: PSA), with the $1.47 per security bid rejected in May.

Abacus said at the time that its net tangible asset value was $1.73 based on an independent valuation, and hence the consortium’s bid was too low.

The consortium’s bid was withdrawn in August, however, not before Ki Corporation ended up with control over 63.5% of the shares in Abacus.

In fact, three shareholders now control almost 95% of Abacus shares, with a company called Abacus Property Group holding 20.9% and Runway Technologies holding 10.2%.

Add to that NSR’s shareholding of just under 5%, which it declared early this year, and you can account for nearly all of the Abacus shares in issue.

With major private equity players running the ruler over NSR, it stands to reason they might do the same for Abacus, and either launch a separate bid or look to take out both entities and combine them into one.

Any such deal could generate significant merger synergies.

Abacus shares were trading 10.4% higher after news of the NSR deal broke, to be changing hands for $1.54.

NSR, meanwhile, asked that its shares be placed in a trading halt pending an announcement “in relation to a potential control transaction for all of NSR’s stapled securities”. The trading halt will remain in place until an announcement is made or until the start of trade on 28 November, the statement to the ASX said.

The post Why are this storage outfit’s shares more than 10% higher today? I’ll tell you my theory appeared first on The Motley Fool Australia.

More reading

• Takeover bid in the wings for this major self storage outfit
• Buy these ASX dividend shares for 4% to 7% yields
• Buy Telstra and these ASX dividend shares for passive income
• The easy way to generate $10,000 of passive income from ASX shares
• Where to invest $5,000 in ASX dividend stocks today

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Brookfield, Brookfield Asset Management, and Brookfield Corporation. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH) shares jumped 8% today after the company delivered a strong set of half-year results, marked by double-digit revenue growth, expanding margins, and a sharp uplift in profitability.

At the time of writing, Fisher & Paykel shares were trading at $34.52 on the ASX and up 8% for the day.

The market’s response was in appreciation of the broad-based strength across both the Hospital and Homecare divisions, as well as an upgrade to full-year guidance.

What did Fisher & Paykel report?

Fisher & Paykel posted operating revenue of $1.09 billion for the six months to 30 September 2025, an increase of 14% on the same period last year, or 12% in constant currency. Net profit after tax rose sharply to $213 million, up 39%, reflecting strong demand for the company’s respiratory care products and the benefits of operational efficiencies.

The hospital division was the standout contributor. Revenue in this segment reached $692.2 million, up 17%, driven by broad-based strength across the consumables portfolio and a particularly strong lift in hardware sales, which grew 21% in constant currency. Notably, this momentum came despite a relatively mild respiratory season, underscoring the structural shift toward high-flow therapy and non-invasive ventilation across global hospitals.

Homecare also delivered steady growth, with revenue rising to $395.9 million, an increase of 10%. The company highlighted robust uptake of its newest obstructive sleep apnea (OSA) masks (including the Nova Nasal and Nova Micro), which are now available across several major markets. These products contributed to an 8% constant-currency lift in OSA mask revenue.

Margins improved materially during the half. Gross margin expanded to 63%, up 110 basis points year on year. Even after accounting for the drag from US tariffs on New Zealand-sourced hospital products, margin gains were supported by continuous improvement initiatives and efficiency gains across the business. Operating profit rose 31%, lifting the operating margin to 26.3%.

The board increased the interim dividend to 19 cents per share, fully imputed and payable on 16 December 2025.

Outlook

In addition to the result, FPH upgraded its full-year outlook. At prevailing exchange rates as of 31 October, the company now expects revenue of $2.17 billion to $2.27 billion (previous guidance provided in August was for revenue of $2.15billion to $2.25billion) and net profit of $410 million to $460 million (previous guidance provided in August was $390m to $440m).

Management noted that last year’s Northern Hemisphere winter was unusually strong for respiratory hospitalisations. Should the upcoming season follow a similar pattern, performance is likely to land toward the higher end of guidance.

Despite the improved earnings outlook, the company emphasised that full-year margins will continue to reflect the impact of US tariffs, which are expected to reduce gross margin by around 75 basis points. Even so, Fisher & Paykel believes its operational efficiency initiatives will continue to offset part of this drag.

Foolish bottom line

Fisher & Paykel Healthcare delivered the combination of growth, margin expansion, and upgraded guidance that investors look for in a high-quality medical technology company. The strength in hospital consumables (even during a softer clinical season) suggests the company’s products are becoming increasingly embedded in global care pathways. Homecare continues to provide a solid second engine of growth, supported by an expanding pipeline of OSA mask innovations.

The result reinforces FPH’s long-term ambition to sustainably double its constant-currency revenue every five to six years. With clinical adoption rising, a refreshed product portfolio gaining traction, and operational efficiency improving, the market’s positive reaction reflects growing confidence that the company is back on a clear upward trajectory.

The post Fisher & Paykel shares surge 8% on half-year results appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today

Motley Fool contributor Kevin Gandiya has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Electro Optic Systems Holdings Ltd (ASX: EOS) shares are catching the eye on Wednesday.

At the time of writing, the ASX defence stock is up 10% to $4.92.

Why is this ASX defence stock surging?

There have been a couple of reasons why investors have been snapping up EOS shares today.

The first is news that it has completed the transaction to acquire the UK-based Interceptor business from MARSS Group. This transaction was previously announced last week on 19 November 2025.

According to the release, under the transaction, EOS has acquired all Interceptor assets, as well as the specialist engineering team that developed the system.

The total investment of 5.5 million euros (approximately $10 million) has been funded from EOS’ existing cash reserves.

Development of this advanced prototype is expected to take a further 12-24 months before full commercial launch. This is expected to require further investment of up to $10 million over the next three years.

Management believes the acquisition broadens EOS’ counter-drone effector portfolio, extends EOS’ software and AI capabilities, and initiates EOS’ presence in the United Kingdom, which is an important AUKUS partner market.

What else?

The ASX defence stock also revealed that it has settled ASIC’s investigation in relation to certain disclosure matters in 2022. The settlement includes an agreed proposed penalty of $4 million, which requires the approval of the Federal Court.

This settlement relates to an investigation by ASIC in connection with the company’s 2022 revenue guidance.

It highlights that it navigated a challenging environment in 2022 marked by strategic, financial, and operational pressures. But it concedes that it accepts ASIC’s conclusion that it breached its continuous disclosure obligations in the period from 25 July 2022 to 31 October 2022.

ASIC has indicated that it intends to bring separate proceedings against Dr Ben Greene (former CEO and current Chief Innovation Officer of EOS). This is in relation to the same revenue guidance issues. Dr Greene is not a party to this settlement.

EOS’ chair, Garry Hounsell, said:

This outcome represents a constructive resolution with ASIC that allows the business to move forward with clarity, removing the potential of protracted litigation on the matter. We believe this outcome is in the best interests of the Company and its shareholders. Since late 2022, we have made significant progress in strengthening our business and remain committed to best-practice and transparent communication. As we look to the future, we are well-positioned to execute our strategic priorities and deliver long-term value for our shareholders.

The post Why is this ASX defence stock rocketing 10% today? appeared first on The Motley Fool Australia.

More reading

• Why DroneShield, EOS, Gentrack, and Web Travel shares are surging today
• Why Accent Group, EOS, Mayne Pharma, and Pilbara Minerals shares are falling today
• Why DPM Metals, Elders, EOS, and Pro Medicus shares are pushing higher today
• Guess which ASX defence stock is jumping 6% on big NATO contract win
• 2 sectors I think could outperform the ASX 200 in 2026

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The iShares S&P 500 ETF (ASX: IVV) share price (or unit price) has done incredibly well for investors over the long term. In the last five years, it has more than doubled, as the chart below shows. This is a good time to ask whether the US share can perform strongly again in 2026.

The S&P 500 represents 500 of the biggest, most profitable businesses listed in the US. The IVV exchange-traded fund (ETF) is invested in many of the world’s most recognisable companies, such as Nvidia, Apple, Microsoft, Amazon.com, Alphabet (Google), Meta Platforms (Facebook and Instagram), Tesla and Berkshire Hathaway.

Collectively, the huge technology companies have gone on a strong run, with the market excited by what they could achieve in the coming years with AI and other advancements.

While forecasts are not guaranteed to become true, let’s take a look at what one investment bank thinks could happen with the S&P 500 in 2026, which would significantly influence the IVV ETF return.

S&P 500 expert expectations

According to CNBC’s reporting, Deutsche Bank predicts that the S&P 500 could reach 8,000 by the end of 2026, driven by another strong year fueled by artificial intelligence. That implies a possible rise of 18% from its current level. Remember, there’s still more than a whole month of 2025 to go.

Jim Reid, the global head of macro and thematic research at Deutsche Bank Research, wrote earlier this week:

Rapid AI investment and adoption will continue to dominate market sentiment. Given the pace of technological advancement, it is difficult to believe this won’t translate into meaningful productivity gains ahead.

However, the ultimate winners and losers will depend on a complex interplay of evolving factors, many of which may not become apparent until after 2026.

The 8,000 year-end S&P 500 target from our US equity strategist — our most optimistic analyst — is notable given his strong track record.

Is this a good time to buy the IVV ETF?

The index is clearly not cheap – at the end of October 2025, it had a price/earnings (P/E) ratio of 30.6x. But, it’s significantly weighted to big tech businesses that are expected to continue growing earnings at a solid pace for years to come, despite their large size.

The US tariff volatility earlier this year presented a clear opportunity to buy shares, and I expect another bout of volatility at some point in the short to medium term. The share market regularly experiences declines from time to time.

If I had a strategy to regularly invest in the IVV ETF, I’d be happy to invest again today because of the ultra-low fees, high-quality holdings and strong track record. But, I believe there are plenty of ASX share opportunities that could perform stronger over the next five years at the current valuations.

The post How much could the iShares S&P 500 ETF (IVV) share price rise in 2026? appeared first on The Motley Fool Australia.

More reading

• What $100 a week in ASX shares could become in 20 years
• How to invest and build wealth globally without leaving the ASX
• $10,000 invested in IVV ETF a year ago is now worth…
• What $5,000 invested in ASX ETFs today could become in 10, 15, and 20 years
• 5 excellent ASX ETFs to buy in December

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Amazon, Apple, Berkshire Hathaway, Meta Platforms, Microsoft, Nvidia, Tesla, and iShares S&P 500 ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool Australia has recommended Alphabet, Amazon, Apple, Berkshire Hathaway, Meta Platforms, Microsoft, Nvidia, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Technology One Limited (ASX: TNE) shares suffered a dramatic sell-off by investors last week after the company posted its full-year earnings. The ASX tech share reported strong financials and revenue growth, but it appears that investors weren’t satisfied with its lack of future growth projections. 

Last Monday, the 17th of November, Technology One shares shed 17% of their value in just one day. There has been some recovery since then, but the stock still has a long way to go to return to pre-reporting season levels.

At the time of writing, ahead of the ASX open on Wednesday morning, the ASX tech share is priced at $30.58 per share. For the month, the shares are 21.02% lower, and for the year-to-date, the ASX tech share is down 0.13%.

The thing is, despite the latest drop in investor sentiment, I still think this ASX tech share could quietly become a global leader. 

And thanks to its new ultra-low share price, it could make a fortune for savvy investors.

Here’s why.

Technology One well-positioned for a boom in growth

TechnologyOne is one of the largest publicly listed software companies in Australia, with offices across six countries. It develops user-friendly enterprise software products that are deeply integrated into customers’ information technology (IT) infrastructures. 

The company boasts more than 1,300 clients across seven industry segments: namely, government, local government, financial services, education, health and community services, utilities, and managed services.

In FY25, the business delivered 18% revenue growth, reaching $610 million, and its annual recurring revenue (ARR) increased 18% to $554.6 million.

The ASX tech company is also pressing forward with its growth strategies. The business continually expands its customer base and acquires new customers. It is also making significant investments in artificial intelligence and developing future growth platforms to help expand its product offerings.

The ASX tech share has also achieved its target net revenue retention (NRR) rate of 15%, which represents the growth in revenue from existing customers since last year. Revenue doubles in five years if it grows at an average annual rate of 15%.  

What do the experts think about the ASX tech share?

Analysts are very bullish on the outlook for Technology One, too, with many predicting a strong upside.

TradingView data shows that out of 18 analysts, 11 still have a buy or strong buy rating on the stock. The maximum upside is as high as $44.55, which implies a 59.5% upside for investors at the time of writing. 

Morgan Stanley analysts recently upgraded the company’s shares to an overweight rating with an improved price target of $36.50. That implies a 19.4% upside is ahead for investors. The broker said it thinks that recent share price weakness has created a very attractive entry point for investors.

The team at Morgans has an accumulate rating on the shares and a more modest $34.50 price target. That implies a 12.8% upside at the time of writing. 

With predicted potential increases like these, it looks like now is a perfect time for investors to get in on the action!

The post This ASX tech share could quietly become a global leader appeared first on The Motley Fool Australia.

More reading

• Bear market alert: ASX 200 tech shares down 24% since September peak
• No savings at 55? Here’s how to still retire with passive income
• Down 21% in 30 days, this top ASX 200 stock now looks on sale to me
• Is the 2025 ASX share selloff your chance to buy generational bargains?
• Buy, hold, sell: James Hardie, Reece, and TechnologyOne shares

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Harvey Norman Holdings Ltd (ASX: HVN) shares are having a strong session on Wednesday.

At the time of writing, the ASX 200 retail share is up 4% to a record high of $7.71.

Why is this ASX 200 share charging higher?

Investors have been scrambling to buy the retail giant’s shares today after responding positively to the release of a trading update ahead of its annual general meeting.

According to the release, Harvey Norman has delivered continued strong aggregated sales revenue in FY 2026 from its wholly-owned company-operated stores in New Zealand, Slovenia, Croatia, Ireland, United Kingdom, majority-owned controlled company-operated stores in Singapore and Malaysia, and independent Harvey Norman, Domayne, and Joyce Mayne branded franchised complexes in Australia

Aggregated sales for the period 1 July 2025 to 20 November, increased by 9.1% over the prior corresponding period. On a comparable store basis, its aggregated sales increased by 8.1% year on year.

In Australia, franchise sales were up 6.5% in total and 6.4% on a comparable store basis.

Foreign exchanged tailwinds have been supportive of the ASX 200 share’s sales growth. Management notes that they were positively impacted by a 9% appreciation in the Euro, a 5.5% appreciation in the UK Pound, a 4.6% appreciation in the Singaporean dollar, and a 7.1% appreciation in the Malaysian Ringgit.

Also supporting its growth was an increase to its store network. Management advised that two new company-operated stores were opened during the period. They are located at Punggol Coast Mall in Singapore and The Beat at Kiara Bay in Malaysia. This brings our total number of overseas company-operated stores to 121.

But its international expansion won’t stop there. Commenting on its opportunity in the United Kingdom, Harvey Norman’s CEO, Katie Page, said:

Our continued expansion in the UK’s West Midlands remains a key market to establish and scale. Home to five million people, it’s a region with strong economic growth and our strategy is focused on capturing those benefits to drive long-term performance. Just over a year ago, we launched Phase One of this strategy with the opening of our flagship store at Merry Hill Shopping Centre. The store has outperformed expectations for footfall in the first year and continues to set the benchmark for customer experience and design.

Phase Two of the expansion is on schedule, and we can confirm our second West Midlands store at the Gracechurch Shopping Centre in Sutton Coldfield will open in 2026. This new location will strengthen brand awareness across the region and bring Harvey Norman closer to customers north of Birmingham, driving further growth and engagement.

Following today’s gain, Harvey Norman shares are now up 60% since this time last year.

The post Why are Harvey Norman shares racing 4% to a new record high? appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Wednesday
• What’s driving a 9% divergence in ASX 200 consumer staples vs. discretionary shares?
• These high-yield ASX dividend shares could rise 13% to 50%
• What are Macquarie’s key picks in the retail space?
• Brokers are recommending these ASX dividend shares to clients

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Harvey Norman. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.